Global Exome Sequencing Market By Product Type (Agilent HaloPlex, Agilent SureSelect) And By End-Users/Application (Mendelian disease and rare syndrome gene discovery, The research of complex diseases) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Exome Sequencing market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Exome Sequencing market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Exome Sequencing industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Exome Sequencing ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Exome Sequencing market.

The following manufacturers are covered in this report:
  • Illumina TruSeq Exome
  • Thermo Fisher
  • Roche
  • Angilent
  • Eurofins
  • Sengenics
  • Ambry
  • Macrogen
  • BGI
  • Novo Gene

The report estimates on the Exome Sequencing market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Exome Sequencing market report consist of all leading industry players, Exome Sequencing business sections, company profile, revenue supply by Exome Sequencing industry sections, global Exome Sequencing market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Exome Sequencing market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Exome Sequencing market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Exome Sequencing market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Exome Sequencing market.

Report Opportunity: Global Exome Sequencing Market

This report delivers an analytical examination of the Exome Sequencing market summarized in broad sections such as
  1. Exome Sequencing Market Summary
  2. Key Commercial Growths in the Exome Sequencing Industry
  3. Market Dynamics Affecting the Exome Sequencing Industry
  4. Important Market Trends and Future Development Scenario of the Exome Sequencing Market
  5. Exome Sequencing Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Exome Sequencing Industry
  7. Positioning of Main Market Players in the Exome Sequencing Industry
  8. Exome Sequencing Market Revenue and Forecast, by Application, 2018 - 2028
  9. Exome Sequencing Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Exome Sequencing Market Revenue and Forecast, by Geography, 2018 - 2028
Exome Sequencing Market Segmentation:

The report provides detailed examination of the Exome Sequencing market on the basis of various segments such as type, application and end-use industry. The Exome Sequencing market is segmented as follows:

Exome Sequencing Market, by Type:
  • Agilent HaloPlex
  • Agilent SureSelect
  • Agilent SureSelect QXT
  • Illumina TruSeq Exome
  • Roche Nimblegen SeqCap
  • MYcroarray MYbaits
Exome Sequencing Market, by Application:
  • Mendelian disease and rare syndrome gene discovery
  • The research of complex diseases
  • Mouse exome sequencing
Geographic Coverage

The report on the Exome Sequencing market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Exome Sequencing Market Revenue and Forecast
  • U.S.
  • Canada
Europe Exome Sequencing Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Exome Sequencing Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Exome Sequencing Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Exome Sequencing Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Exome Sequencing Market Snapshot
          2.1.1. Global Exome Sequencing Market By Type,2019
               2.1.1.1.Agilent HaloPlex
               2.1.1.2.Agilent SureSelect
               2.1.1.3.Agilent SureSelect QXT
               2.1.1.4.Illumina TruSeq Exome
               2.1.1.5.Roche Nimblegen SeqCap
               2.1.1.6.MYcroarray MYbaits
          2.1.2. Global Exome Sequencing Market By Application,2019
               2.1.2.1.Mendelian disease and rare syndrome gene discovery
               2.1.2.2.The research of complex diseases
               2.1.2.3.Mouse exome sequencing
          2.1.3. Global Exome Sequencing Market By End-use,2019
          2.1.4. Global Exome Sequencing Market By Geography,2019

3. Global Exome Sequencing Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Exome Sequencing Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Exome Sequencing Market Size (US$), By Type, 2018 – 2028

5. Global Exome Sequencing Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Exome Sequencing Market Size (US$), By Application, 2018 – 2028

6. Global Exome Sequencing Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Exome Sequencing Market Size (US$), By End-use, 2018 – 2028

7. Global Exome Sequencing Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Exome Sequencing Market Analysis, 2018 – 2028 
          7.2.1. North America Exome Sequencing Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Exome Sequencing Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Exome Sequencing Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Exome Sequencing Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Exome Sequencing Market Analysis, 2018 – 2028 
          7.3.1.  Europe Exome Sequencing Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Exome Sequencing Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Exome Sequencing Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Exome Sequencing Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Exome Sequencing Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Exome Sequencing Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Exome Sequencing Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Exome Sequencing Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Exome Sequencing Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Exome Sequencing Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Exome Sequencing Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Exome Sequencing Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Exome Sequencing Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Exome Sequencing Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Exome Sequencing Market Analysis, 2018 – 2028 
          7.6.1.  MEA Exome Sequencing Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Exome Sequencing Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Exome Sequencing Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Exome Sequencing Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Exome Sequencing Providers
        8.4.1 Illumina TruSeq Exome
                8.1.1 Business Description
                8.1.2 Illumina TruSeq Exome Geographic Operations
                8.1.3 Illumina TruSeq Exome Financial Information
                8.1.4 Illumina TruSeq Exome Product Positions/Portfolio
                8.1.5 Illumina TruSeq Exome Key Developments
        8.4.2 Thermo Fisher
                8.2.1 Business Description
                8.2.2 Thermo Fisher Geographic Operations
                8.2.3 Thermo Fisher Financial Information
                8.2.4 Thermo Fisher Product Positions/Portfolio
                8.2.5 Thermo Fisher Key Developments
        8.4.3 Roche
                8.3.1 Business Description
                8.3.2 Roche Geographic Operations
                8.3.3 Roche Financial Information
                8.3.4 Roche Product Positions/Portfolio
                8.3.5 Roche Key Developments
        8.4.4 Angilent
                8.4.1 Business Description
                8.4.2 Angilent Geographic Operations
                8.4.3 Angilent Financial Information
                8.4.4 Angilent Product Positions/Portfolio
                8.4.5 Angilent Key Developments
        8.4.5 Eurofins
                8.5.1 Business Description
                8.5.2 Eurofins Geographic Operations
                8.5.3 Eurofins Financial Information
                8.5.4 Eurofins Product Positions/Portfolio
                8.5.5 Eurofins Key Developments
        8.4.6 Sengenics
                8.6.1 Business Description
                8.6.2 Sengenics Geographic Operations
                8.6.3 Sengenics Financial Information
                8.6.4 Sengenics Product Positions/Portfolio
                8.6.5 Sengenics Key Developments
        8.4.7 Ambry
                8.7.1 Business Description
                8.7.2 Ambry Geographic Operations
                8.7.3 Ambry Financial Information
                8.7.4 Ambry Product Positions/Portfolio
                8.7.5 Ambry Key Developments
        8.4.8 Macrogen
                8.8.1 Business Description
                8.8.2 Macrogen Geographic Operations
                8.8.3 Macrogen Financial Information
                8.8.4 Macrogen Product Positions/Portfolio
                8.8.5 Macrogen Key Developments
        8.4.9 BGI
                8.9.1 Business Description
                8.9.2 BGI Geographic Operations
                8.9.3 BGI Financial Information
                8.9.4 BGI Product Positions/Portfolio
                8.9.5 BGI Key Developments
        8.4.10 Novo Gene
                8.10.1 Business Description
                8.10.2 Novo Gene Geographic Operations
                8.10.3 Novo Gene Financial Information
                8.10.4 Novo Gene Product Positions/Portfolio
                8.10.5 Novo Gene Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Exome Sequencing Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Exome Sequencing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Exome Sequencing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Exome Sequencing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Exome Sequencing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Exome Sequencing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Exome Sequencing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Exome Sequencing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Exome Sequencing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Exome Sequencing Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Exome Sequencing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Exome Sequencing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Exome Sequencing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Exome Sequencing Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Exome Sequencing Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Exome Sequencing Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Exome Sequencing: Market Segmentation 
FIG. 2 Global Exome Sequencing Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Exome Sequencing Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Exome Sequencing Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Exome Sequencing Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Exome Sequencing Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Exome Sequencing Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Exome Sequencing Providers, 2019
FIG. 11 Global Exome Sequencing Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Exome Sequencing Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Exome Sequencing Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Exome Sequencing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Exome Sequencing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Exome Sequencing Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Exome Sequencing Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Exome Sequencing Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Exome Sequencing market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1656

6963

OUR CLIENT